Jay Young Rhew

Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (HOST-REDUCE-POLYTECH-ACS): an open-label, multicentre, non-inferiority randomised trial

Hyo‐Soo Kim, Jeehoon Kang, Doyeon Hwang et al. · The Lancet · 2020 · 198 citations

Medicine, Cardiology, Pharmacotherapy +17

A Randomized Comparison of Platinum Chromium-Based Everolimus-Eluting Stents Versus Cobalt Chromium-Based Zotarolimus-Eluting Stents in All-Comers Receiving Percutaneous Coronary Intervention

Kyung Woo Park, Si‐Hyuck Kang, Hyun‐Jae Kang et al. · Journal of the American College of Cardiology · 2014 · 81 citations · Full text

Medicine, Cardiology, Clinical Cardiology +12

Everolimus-Eluting Xience V/Promus Versus Zotarolimus-Eluting Resolute Stents in Patients With Diabetes Mellitus

Kyung Woo Park, Joo Myung Lee, Si‐Hyuck Kang et al. · JACC: Cardiovascular Interventions · 2014 · 66 citations

Medicine, Cardiology, Pharmacotherapy +11

Clinical Effects of Hypertension on the Mortality of Patients with Acute Myocardial Infarction

Dong Goo Kang, Myung Ho Jeong, Yongkeun Ahn et al. · Journal of Korean Medical Science · 2009 · 36 citations · Full text

Medicine, Cardiology, Internal Medicine +6

Culprit-Lesion-Only Versus Multivessel Revascularization Using Drug-Eluting Stents in Patients With ST-Segment Elevation Myocardial Infarction: A Korean Acute Myocardial Infarction Registry-Based Analysis

Hyun Su Jo, Jong‐Seon Park, Jang Won Sohn et al. · Korean Circulation Journal · 2011 · 36 citations · Full text

Medicine, Cardiology, Cardiovascular Pharmacotherapy +13